Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462565 | SCV000563690 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568309 | SCV000674953 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000568309 | SCV002527715 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-18 | criteria provided, single submitter | curation | |
Ce |
RCV003431042 | SCV004151959 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | SDHA: BP4, BP7 |
Breakthrough Genomics, |
RCV003431042 | SCV005256859 | likely benign | not provided | criteria provided, single submitter | not provided |